Skip to main content
. 2020 May 29;15(5):e0233485. doi: 10.1371/journal.pone.0233485

Fig 5. Fatty acid supplementation can overcome growth inhibition by PYRC and EQI treatment in S. aureus.

Fig 5

S. aureus was grown in the presence of drug in LB+BSA (No FAs; black circle), LB+BSA plus a15:0/a17:0 (500 μM, 2:1 ratio of a15:0 to a17:0; red triangle), or LB+BSA plus 18:1Δ9 (500 μM; blue square). Mean data of two independent experiment run in triplicate are shown ± standard error of the mean. Significance was determined using a two-tailed, unpaired t test. *, p < 0.05 (No FAs vs a15:0/a17:0): †, p < 0.05 (No FAs vs 18:1Δ9). A) Percent growth of S. aureus in the presence of PYRC. B) Percent growth of S. aureus in the presence of EQI.